Biotech Startups: Take Your Time
Biotech Startups: Take Your Time
Until startups’ products are close to gaining approval, there’s no reason why smart investors would want to share the risks
Biotech Startups: Take Your Time
Until startups’ products are close to gaining approval, there’s no reason why smart investors would want to share the risks
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!